Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Actin microfilament aggregation induced by withaferin A is mediated by annexin II

Abstract

The actin cytoskeleton supports diverse cellular processes such as endocytosis, oriented growth, adhesion and migration1. The dynamic nature of the cytoskeleton, however, has made it difficult to define the roles of the many accessory molecules that modulate actin organization, especially the multifunctional adapter protein annexin II (refs. 2,3). We now report that the compound withaferin A (1) can alter cytoskeletal architecture in a previously unknown manner by covalently binding annexin II and stimulating its basal F-actin cross-linking activity. Drug-mediated disruption of F-actin organization is dependent on annexin II expression by cells and markedly limits their migratory and invasive capabilities at subcytotoxic concentrations. Given the extensive ethnobotanical history of withaferin-containing plant preparations in the treatment of cancer and inflammatory and neurological disorders, we suggest that annexin II represents a feasible, previously unexploited target for therapeutic intervention by small-molecule drugs4.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Stable and specific binding of annexin II by withaferin.
Figure 2: Molecular modeling of the withaferin binding site in human annexin II.
Figure 3: Effect of withaferin on AIIt function in vitro.
Figure 4: Withaferin disrupts the actin cytoskeleton in an annexin II–dependent manner.
Figure 5: Effects of withaferin on intact cells.

Similar content being viewed by others

References

  1. Gardel, M.L. et al. Elastic behavior of cross-linked and bundled actin networks. Science 304, 1301–1305 (2004).

    Article  CAS  Google Scholar 

  2. Revenu, C., Athman, R., Robine, S. & Louvard, D. The co-workers of actin filaments: from cell structures to signals. Nat. Rev. Mol. Cell Biol. 5, 635–646 (2004).

    Article  CAS  Google Scholar 

  3. Hayes, M.J., Rescher, U., Gerke, V. & Moss, S.E. Annexin-actin interactions. Traffic 5, 571–576 (2004).

    Article  CAS  Google Scholar 

  4. Mishra, L., Singh, B. & Dagenais, S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha). Altern. Med. Rev. 5, 334–346 (2000).

    CAS  PubMed  Google Scholar 

  5. Budhiraja, R.D., Krishan, P. & Sudhir, S. Biological activity of withanolides. J. Sci. Ind. Res. (India) 59, 904–911 (2000).

    CAS  Google Scholar 

  6. Waisman, D.M. Annexin II tetramer: structure and function. Mol. Cell. Biochem. 149–150, 301–322 (1995).

    Article  Google Scholar 

  7. Ayala-Sanmartin, J., Gouache, P. & Henry, J.P. N-Terminal domain of annexin 2 regulates Ca(2+)-dependent membrane aggregation by the core domain: a site directed mutagenesis study. Biochemistry 39, 15190–15198 (2000).

    Article  CAS  Google Scholar 

  8. MacLeod, T.J., Kwon, M., Filipenko, N.R. & Waisman, D.M. Phospholipid-associated annexin A2–S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J. Biol. Chem. 278, 25577–25584 (2003).

    Article  CAS  Google Scholar 

  9. Filipenko, N.R. & Waisman, D.M. The C terminus of annexin II mediates binding to F-actin. J. Biol. Chem. 276, 5310–5315 (2001).

    Article  CAS  Google Scholar 

  10. Caplan, J.F., Filipenko, N.R., Fitzpatrick, S.L. & Waisman, D.M. Regulation of annexin A2 by reversible glutathionylation. J. Biol. Chem. 279, 7740–7750 (2004).

    Article  CAS  Google Scholar 

  11. Hofmann, A. et al. Interactions of benzodiazepine derivatives with annexins. J. Biol. Chem. 273, 2885–2894 (1998).

    Article  CAS  Google Scholar 

  12. Burger, A. et al. The crystal structure and ion channel activity of human annexin II, a peripheral membrane protein. J. Mol. Biol. 257, 839–847 (1996).

    Article  CAS  Google Scholar 

  13. Singh, T.K. & Liu, L. Modification of cysteine residues by N-ethylmaleimide inhibits annexin II tetramer mediated liposome aggregation. Arch. Biochem. Biophys. 381, 235–240 (2000).

    Article  CAS  Google Scholar 

  14. Jones, P.G., Moore, G.J. & Waisman, D.M. A nonapeptide to the putative F-actin binding site of annexin-II tetramer inhibits its calcium-dependent activation of actin filament bundling. J. Biol. Chem. 267, 13993–13997 (1992).

    CAS  PubMed  Google Scholar 

  15. Zobiack, N., Gerke, V. & Rescher, U. Complex formation and submembranous localization of annexin 2 and S100A10 in live HepG2 cells. FEBS Lett. 500, 137–140 (2001).

    Article  CAS  Google Scholar 

  16. Puisieux, A., Ji, J. & Ozturk, M. Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. Biochem. J. 313, 51–55 (1996).

    Article  CAS  Google Scholar 

  17. Mai, J., Finley, R.L., Jr, Waisman, D.M. & Sloane, B.F. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806–12812 (2000).

    Article  CAS  Google Scholar 

  18. Kwon, M. et al. Identification of annexin II heterotetramer as a plasmin reductase. J. Biol. Chem. 277, 10903–10911 (2002).

    Article  CAS  Google Scholar 

  19. Menell, J.S. et al. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340, 994–1004 (1999).

    Article  CAS  Google Scholar 

  20. Ishii, H. et al. Potential role of recombinant annexin II in diabetic vascular injury. Ann. NY Acad. Sci. 947, 308–311 (2001).

    Article  CAS  Google Scholar 

  21. Oliferenko, S. et al. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 146, 843–854 (1999).

    Article  CAS  Google Scholar 

  22. Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).

    Article  CAS  Google Scholar 

  23. Yates, J.R., III, Eng, J.K., McCormack, A.L. & Schieltz, D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67, 1426–1436 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank V. Gerke and J. Ayala-Sanmartin for their gifts of recombinant annexin II and p11 expression plasmids; D.M. Waisman for human recombinant AIIt; G. Tsaprailis and C. Payne for suggestions; and the University of Arizona Electron Microscopy Core; the SWEHSC Proteomics Core and C. McLellan for technical assistance. The assistance of K. Wijeratne in obtaining physical and spectral data for biotinylated withaferin A is also appreciated. This work was supported by US National Institutes of Health (NIH) grants R21-CA091056 (L.W.) and R01-CA090265 (A.A.L.G.). Fellowship support was provided to R.F. by the Tee Up for Tots Foundation. Support for the Southwest Environmental Health Sciences Center was provided by National Institute of Environmental Health Sciences grant ES06694 and NIH/National Cancer Institute grant CA023074-26.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luke Whitesell.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Effect of withaferin (WA) on cell morphology and survival. (PDF 2456 kb)

Supplementary Fig. 2

Design and synthesis of biotinyl-withaferin (B-WA) for solid phase immobilization. (PDF 582 kb)

Supplementary Fig. 3

Identification of annexin II (AII) as a target of withaferin (WA). (PDF 469 kb)

Supplementary Fig. 4

Withaferin (WA) binds to AIIt but not other annexin family members. (PDF 2241 kb)

Supplementary Fig. 5

5 Mass spectroscopy identification of withaferin (WA) adduct site in annexin II (AII). (PDF 467 kb)

Supplementary Fig. 6

Enforced expression of AIIt in HepG2 cells. (PDF 496 kb)

Supplementary Methods (PDF 70 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Falsey, R., Marron, M., Gunaherath, G. et al. Actin microfilament aggregation induced by withaferin A is mediated by annexin II. Nat Chem Biol 2, 33–38 (2006). https://doi.org/10.1038/nchembio755

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio755

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing